{"id":1574,"date":"2022-08-10T16:30:45","date_gmt":"2022-08-10T14:30:45","guid":{"rendered":"https:\/\/dextechmedical.com\/?p=1574"},"modified":"2022-08-10T15:52:38","modified_gmt":"2022-08-10T13:52:38","slug":"dextech-medicals-application-for-myeloma-study-approved","status":"publish","type":"post","link":"https:\/\/dextechmedical.com\/en\/dextech-medicals-application-for-myeloma-study-approved\/","title":{"rendered":"DexTech Medical’s application for myeloma study approved"},"content":{"rendered":"
\n
\n
\n

The application for a phase1 study regarding OsteoDex’s effect on patients with multiple myeloma that was submitted to the Medical Products Agency on 2022-06-23 has been approved and granted permission 2022-08-10. The study will include 20 patients and be conducted at 5 hospital centers in Sweden and Norway. The start of the study is expected to be Q3-2022 – Q1-2023 and is expected to be completed Q3-2024.<\/p>\n

For more information about DexTech, please contact:<\/p>\n

Go\u0308sta Lundgren \u2013 CFO
\nDexTech Medical AB
\nPhone: +46 (0) 707104788
\nE-post: gosta.lundgren@dextechmedical.com<\/p>\n

This information is information that DexTech Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 10 August 2022.<\/p>\n

220810 – PR – DexTech – Application for myeloma study approved<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The application for a phase1 study regarding OsteoDex’s effect on patients with multiple myeloma that was submitted to the Medical Products Agency on 2022-06-23 has been approved and granted permission […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-1574","post","type-post","status-publish","format-standard","hentry","category-okategoriserade-en"],"acf":[],"yoast_head":"\nDexTech Medical's application for myeloma study approved | DexTech<\/title>\n<meta name=\"description\" content=\"The application for a phase1 study regarding OsteoDex's effect on patients with multiple myeloma that was submitted to the Medical Products Agency on\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DexTech Medical's application for myeloma study approved | DexTech\" \/>\n<meta property=\"og:description\" content=\"The application for a phase1 study regarding OsteoDex's effect on patients with multiple myeloma that was submitted to the Medical Products Agency on\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/\" \/>\n<meta property=\"og:site_name\" content=\"DexTech\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-10T14:30:45+00:00\" \/>\n<meta name=\"author\" content=\"G\u00f6sta Lundgren\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"G\u00f6sta Lundgren\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/\",\"url\":\"https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/\",\"name\":\"DexTech Medical's application for myeloma study approved | DexTech\",\"isPartOf\":{\"@id\":\"https:\/\/dextechmedical.com\/#website\"},\"datePublished\":\"2022-08-10T14:30:45+00:00\",\"author\":{\"@id\":\"https:\/\/dextechmedical.com\/#\/schema\/person\/7d6388cae097fcab5953ef5d1733040c\"},\"description\":\"The application for a phase1 study regarding OsteoDex's effect on patients with multiple myeloma that was submitted to the Medical Products Agency on\",\"breadcrumb\":{\"@id\":\"https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/dextechmedical.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DexTech Medical’s application for myeloma study approved\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dextechmedical.com\/#website\",\"url\":\"https:\/\/dextechmedical.com\/\",\"name\":\"DexTech\",\"description\":\"Ett svenskt forskningsf\u00f6retag specialiserat p\u00e5 urologisk onkologi fr\u00e4mst prostatacancer\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dextechmedical.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/dextechmedical.com\/#\/schema\/person\/7d6388cae097fcab5953ef5d1733040c\",\"name\":\"G\u00f6sta Lundgren\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dextechmedical.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5e00bd305cedebf5b9069290209926ac27dd0b062e7cdfd04870526f70b02470?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5e00bd305cedebf5b9069290209926ac27dd0b062e7cdfd04870526f70b02470?s=96&d=mm&r=g\",\"caption\":\"G\u00f6sta Lundgren\"},\"sameAs\":[\"https:\/\/dextechmedical.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DexTech Medical's application for myeloma study approved | DexTech","description":"The application for a phase1 study regarding OsteoDex's effect on patients with multiple myeloma that was submitted to the Medical Products Agency on","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/","og_locale":"en_US","og_type":"article","og_title":"DexTech Medical's application for myeloma study approved | DexTech","og_description":"The application for a phase1 study regarding OsteoDex's effect on patients with multiple myeloma that was submitted to the Medical Products Agency on","og_url":"https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/","og_site_name":"DexTech","article_published_time":"2022-08-10T14:30:45+00:00","author":"G\u00f6sta Lundgren","twitter_misc":{"Written by":"G\u00f6sta Lundgren","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/","url":"https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/","name":"DexTech Medical's application for myeloma study approved | DexTech","isPartOf":{"@id":"https:\/\/dextechmedical.com\/#website"},"datePublished":"2022-08-10T14:30:45+00:00","author":{"@id":"https:\/\/dextechmedical.com\/#\/schema\/person\/7d6388cae097fcab5953ef5d1733040c"},"description":"The application for a phase1 study regarding OsteoDex's effect on patients with multiple myeloma that was submitted to the Medical Products Agency on","breadcrumb":{"@id":"https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dextechmedical.com\/dextech-medicals-ansokan-for-myelom-studie-godkand\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dextechmedical.com\/en\/"},{"@type":"ListItem","position":2,"name":"DexTech Medical’s application for myeloma study approved"}]},{"@type":"WebSite","@id":"https:\/\/dextechmedical.com\/#website","url":"https:\/\/dextechmedical.com\/","name":"DexTech","description":"Ett svenskt forskningsf\u00f6retag specialiserat p\u00e5 urologisk onkologi fr\u00e4mst prostatacancer","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dextechmedical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/dextechmedical.com\/#\/schema\/person\/7d6388cae097fcab5953ef5d1733040c","name":"G\u00f6sta Lundgren","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dextechmedical.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5e00bd305cedebf5b9069290209926ac27dd0b062e7cdfd04870526f70b02470?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5e00bd305cedebf5b9069290209926ac27dd0b062e7cdfd04870526f70b02470?s=96&d=mm&r=g","caption":"G\u00f6sta Lundgren"},"sameAs":["https:\/\/dextechmedical.com"]}]}},"_links":{"self":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/posts\/1574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/comments?post=1574"}],"version-history":[{"count":1,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/posts\/1574\/revisions"}],"predecessor-version":[{"id":1577,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/posts\/1574\/revisions\/1577"}],"wp:attachment":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/media?parent=1574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/categories?post=1574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/tags?post=1574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}